Merck & Co., Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before April 14, 2025 to Discuss Your Rights - MRK
Portfolio Pulse from
Merck & Co. is being sued for securities law violations related to its Gardasil sales projections in China. The lawsuit alleges that the company misled investors about expected revenue of $11 billion by 2030. On February 4, 2025, Merck announced it would cease Gardasil shipments to China, causing its stock to drop over 9% in a single day.
March 27, 2025 | 6:00 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
The class action lawsuit alleges securities fraud related to Gardasil sales projections in China, which could result in financial penalties and investor trust erosion.
The lawsuit directly targets Merck's representations about Gardasil sales, alleging material misstatements that caused investor losses. The 9% stock drop and potential legal consequences suggest negative short-term implications.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100